About Jecure
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure combines emerging NASH biology with an elite discovery team of veteran pharma and biotech scientists.
Learn More About JecureNews
- Feb 15, 2017Versant Ventures Launches Jecure Therapeutics
- Jan 5, 2017Jecure Therapeutics Founder Ariel Feldstein M.D. Elected to the American Society of Clinical Investigation (ASCI)
Contact Jecure
Jecure Therapeutics4757 Nexus Center Drive, Suite 150
San Diego, CA 92121
(619) 541-8699 Email:
info@jecuretx.com